Telmisartan/amlodipine/indapamide

< Telmisartan < amlodipine

Telmisartan/amlodipine/indapamide
Combination of
Telmisartanangiotensin II receptor blocker
Amlodipinedihydropyridine calcium channel blocker
Indapamidethiazide-like diuretic
Clinical data
Trade namesWidaplik
License data
Pregnancy
category
Routes of
administration		By mouth
ATC code
  • None
Legal status
Legal status

Telmisartan/amlodipine/indapamide, sold under the brand name Widaplik, is a fixed-dose combination medication used for the treatment of hypertension (high blood pressure). It contains telmisartan, an angiotensin II receptor blocker; amlodipine, as the besilate salt, a dihydropyridine calcium channel blocker; and indapamide, a thiazide-like diuretic.

The combination telmisartan/amlodipine/indapamide was approved for medical use in the United States in June 2025.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.